Abstract
From the 1980s onward, PET molecular imaging has yielded a wealth of information on the molecular and structural biology of neurodegeneration in patients with Huntington's disease. While currently not in use for day-to-day diagnostic or predictive clinical purposes in patients, it may acquire new relevance. In this review, I will outline its applications to the study of human preclinical and clinical disease, to our understanding of the neurobiology of Huntington's, as well as in the field of experimental therapeutics.
Author supplied keywords
Cite
CITATION STYLE
Kremer, H. P. H. B. (2020). PET in Huntington’s Disease. In PET and SPECT in Neurology (pp. 783–798). Springer International Publishing. https://doi.org/10.1007/978-3-030-53168-3_28
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
